Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review

BackgroundCurrent methods for assessing strength of evidence prioritize the contributions of randomized controlled trials (RCTs). The objective of this study was to characterize strength of evidence (SOE) tools in recent use, identify their application to lifestyle interventions for improved longevity, vitality, or successful aging, and to assess implications of the findings.MethodsThe search strategy was created in PubMed and modified as needed for four additional databases: Embase, AnthropologyPlus, PsycINFO, and Ageline, supplemented by manual searching. Systematic reviews and meta-analyses of intervention trials or observational studies relevant to lifestyle intervention were included if they used a specified SOE tool. Data was collected for each SOE tool. Conditions necessary for assigning the highest SOE grading and treatment of prospective cohort studies within each SOE rating framework were summarized. The expert panel convened to discuss the implications of findings for assessing evidence in the domain of lifestyle medicine.Results and conclusionsA total of 15 unique tools were identified. Ten were tools developed and used by governmental agencies or other equivalent professional bodies and were applicable in a variety of settings. Of these 10, four require consistent results from RCTs of high quality to award the highest rating of evidence. Most SOE tools include prospective cohort studies only to note their secondary contribution to overall SOE as compared to RCTs. We developed a new construct, Hierarchies of Evidence Applied to Lifestyle Medicine (HEALM), to illustrate the feasibility of a tool based on the specific contributions of diverse research methods to understanding lifetime effects of health behaviors. Assessment of evidence relevant to lifestyle medicine requires a potential adaptation of SOE approaches when outcomes and/or exposures obviate exclusive or preferential reliance on RCTs. This systematic review was registered with the International Prospective Register of Systematic Reviews, PROSPERO [CRD42018082148].

[1]  Stephan Milosavljevic,et al.  A systematic review of studies using pedometers as an intervention for musculoskeletal diseases , 2014, BMC Musculoskeletal Disorders.

[2]  F. Speizer,et al.  Oral contraceptive use and mortality after 36 years of follow-up in the Nurses’ Health Study: prospective cohort study , 2014, BMJ : British Medical Journal.

[3]  W. Willett,et al.  The Misuse of Meta-analysis in Nutrition Research. , 2017, JAMA.

[4]  Patricia Dolan Mullen,et al.  Developing an Evidence-Based Guide to Community Preventive Services—Methods , 2000 .

[5]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[6]  Animal Models and Basic Science—Bench to Bedside: Session Introduction , 2011 .

[7]  F. Infurna,et al.  Associations of Lifetime Trauma and Chronic Stress With C-reactive Protein in Adults Ages 50 Years and Older: Examining the Moderating Role of Perceived Control , 2017, Psychosomatic medicine.

[8]  S. Kumanyika,et al.  Guiding Principles for Developing Dietary Reference Intakes Based on Chronic Disease , 2017 .

[9]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[10]  Nancy D Berkman,et al.  Grading the strength of a body of evidence when assessing health care interventions: an EPC update. , 2015, Journal of clinical epidemiology.

[11]  C. la Vecchia,et al.  Evidence-based practice within nutrition: what are the barriers for improving the evidence and how can they be dealt with? , 2017, Trials.

[12]  W. Willett.  Diet and health—finding a path to Veritas , 2018, European Journal of Epidemiology.

[13]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[14]  Eyal Oren,et al.  The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States , 2018, JAMA.

[15]  O. Manor,et al.  In defense of the randomized controlled trial for health promotion research. , 2006, American journal of public health.

[16]  Virginia Moyer,et al.  The US Preventive Services Task Force , 2015, North Carolina Medical Journal.

[17]  W. Zijlstra,et al.  Effects of remote feedback in home-based physical activity interventions for older adults , 2013 .

[18]  J. Buckley,et al.  Long-term dietary intervention trials: critical issues and challenges , 2012, Trials.

[19]  Jos M G A Schols,et al.  Limitations in Activities of Daily Living in Community-Dwelling People Aged 75 and Over: A Systematic Literature Review of Risk and Protective Factors , 2016, PloS one.

[20]  P D Mullen,et al.  Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. , 2000, American journal of preventive medicine.

[21]  L M Bouter,et al.  A systematic review of controlled clinical trials on the prevention of back pain in industry. , 1997, Occupational and environmental medicine.

[22]  E. Hannan.  Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. , 2008, JACC. Cardiovascular interventions.

[23]  Kath Wright,et al.  PTSD in prison settings: A systematic review and meta-analysis of comorbid mental disorders and problematic behaviours , 2019, PloS one.

[24]  Willem van Mechelen,et al.  Physical activity and performance at school: a systematic review of the literature including a methodological quality assessment. , 2012, Archives of pediatrics & adolescent medicine.

[25]  A. Heinonen,et al.  Evidence for the effectiveness of walking training on walking and self-care after stroke: a systematic review and meta-analysis of randomized controlled trials. , 2014, Journal of rehabilitation medicine.

[26]  L. Green,et al.  Limitations of the randomized controlled trial in evaluating population-based health interventions. , 2007, American journal of preventive medicine.

[27]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[28]  H. Burger.  Climacteric: The Journal of the International Menopause Society , 1998 .

[29]  A. Steiber,et al.  Academy of Nutrition and Dietetics Methodology for Conducting Systematic Reviews for the Evidence Analysis Library. , 2016, Journal of the Academy of Nutrition and Dietetics.

[30]  Lewis H Kuller,et al.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.

[31]  Robert F Kushner,et al.  Lifestyle medicine: the future of chronic disease management , 2013, Current opinion in endocrinology, diabetes, and obesity.

[32]  R. Slavin.  Best evidence synthesis: an intelligent alternative to meta-analysis. , 1995, Journal of clinical epidemiology.

[33]  Ross L Prentice,et al.  Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. , 2005, American journal of epidemiology.

[34]  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. , 1994, Annals of epidemiology.

[35]  Lawrence Green,et al.  HEALTH PROMOTION AND THE COMPRESSION OF MORBIDITY , 1989, The Lancet.

[36]  B. Singer,et al.  From Evidence Based Medicine to Medicine Based Evidence. , 2017, The American journal of medicine.

[37]  S. Silverman,et al.  From randomized controlled trials to observational studies. , 2009, The American journal of medicine.

[38]  J. Prochaska,et al.  A review of correlates of physical activity of children and adolescents. , 2000, Medicine and science in sports and exercise.

[39]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[40]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[41]  J. Ioannidis.  We need more randomized trials in nutrition-preferably large, long-term, and with negative results. , 2016, The American journal of clinical nutrition.

[42]  Douglas K Owens,et al.  AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. , 2010, Journal of clinical epidemiology.

[43]  L. Bero,et al.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. , 2014, The Cochrane database of systematic reviews.

[44]  J. J. Andonian.  Maxcy-Rosenau-Last Public Health and Preventive Medicine , 1999 .

[45]  A. Feinstein,et al.  Problems in the "evidence" of "evidence-based medicine". , 1997, The American journal of medicine.

[46]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[47]  P. Sarrel,et al.  The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years. , 2013, American journal of public health.

[48]  P. Sarrel,et al.  Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? , 2018, Climacteric : the journal of the International Menopause Society.

[49]  T. Jørgensen,et al.  Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial , 2014, BMJ : British Medical Journal.

[50]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[51]  J. Ioannidis,et al.  Disclosures in Nutrition Research: Why It Is Different. , 2017, JAMA.

[52]  E. Rimm,et al.  Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis , 2018, The Lancet. Public health.

[53]  J. Ioannidis.  Some main problems eroding the credibility and relevance of randomized trials. , 2008, Bulletin of the NYU hospital for joint diseases.

[54]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[55]  A. Carvalho,et al.  Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta‐analyses , 2018, Acta psychiatrica Scandinavica.

[56]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[57]  E. Guérin.  Disentangling vitality, well-being, and quality of life: a conceptual examination emphasizing their similarities and differences with special application in the physical activity domain. , 2012, Journal of physical activity & health.

[58]  D L Katz,et al.  Can we say what diet is best for health? , 2014, Annual review of public health.

[59]  T. Frieden.  Evidence for Health Decision Making — Beyond Randomized, Controlled Trials: The Changing Face of Clinical Trials , 2017, The New England journal of medicine.

[60]  G. Grandes,et al.  Evidence from interventions based on theoretical models for lifestyle modification (physical activity, diet, alcohol and tobacco use) in primary care settings: A systematic review. , 2015, Preventive medicine.

[61]  Juha Karvanen,et al.  Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up study in Finland. , 2015, International journal of epidemiology.

[62]  Hossam M. Hammady,et al.  Rayyan—a web and mobile app for systematic reviews , 2016, Systematic Reviews.

[63]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[64]  A. Stuck,et al.  Risk factors for functional status decline in community-living elderly people: a systematic literature review. , 1999, Social science & medicine.

[65]  L. Bero,et al.  An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines , 2018, Nutrition reviews.

[66]  G. Bray,et al.  Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions , 2018, Diabetologia.